LIQUIDIA TECHNOLOGIES ($LQDA) posted quarterly earnings results for Q4 2025 on Thursday, March 5th. The company reported earnings of $0.15 per share, missing estimates of $0.18 by $0.03. The company also reported revenue of $92,020,000, beating estimates of $85,306,680 by $6,713,320.
You can see Quiver Quantitative's $LQDA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LIQUIDIA TECHNOLOGIES Insider Trading Activity
LIQUIDIA TECHNOLOGIES insiders have traded $LQDA stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.
Here’s a breakdown of recent trading of $LQDA stock by insiders over the last 6 months:
- ROGER JEFFS (Chief Executive Officer) has made 0 purchases and 2 sales selling 86,871 shares for an estimated $2,967,522.
- RAJEEV SAGGAR (Chief Medical Officer) has made 0 purchases and 4 sales selling 97,850 shares for an estimated $2,843,337.
- JASON ADAIR (Chief Business Officer) has made 0 purchases and 6 sales selling 54,947 shares for an estimated $1,730,557.
- MICHAEL KASETA (CFO and COO) has made 0 purchases and 3 sales selling 49,728 shares for an estimated $1,692,156.
- DANA BOYLE (Chief Accounting Officer) has made 0 purchases and 7 sales selling 44,245 shares for an estimated $1,270,309.
- RUSSELL SCHUNDLER (General Counsel) has made 0 purchases and 3 sales selling 36,200 shares for an estimated $1,239,445.
- RAMAN SINGH sold 45,524 shares for an estimated $1,174,974
- SCOTT MOOMAW (Chief Commercial Officer) has made 0 purchases and 3 sales selling 26,264 shares for an estimated $910,009.
- SARAH KREPP (Chief Human Resource Officer) has made 0 purchases and 3 sales selling 15,077 shares for an estimated $539,466.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LIQUIDIA TECHNOLOGIES Hedge Fund Activity
We have seen 119 institutional investors add shares of LIQUIDIA TECHNOLOGIES stock to their portfolio, and 125 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC removed 2,078,188 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $71,676,704
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 1,616,778 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $36,765,531
- TYRO CAPITAL MANAGEMENT LLC removed 1,241,839 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $28,239,418
- MPM BIOIMPACT LLC added 1,200,869 shares (+600.4%) to their portfolio in Q4 2025, for an estimated $41,417,971
- BANK OF AMERICA CORP /DE/ added 1,162,074 shares (+151.8%) to their portfolio in Q4 2025, for an estimated $40,079,932
- TANG CAPITAL MANAGEMENT LLC removed 1,143,759 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,448,247
- MILLENNIUM MANAGEMENT LLC removed 869,087 shares (-89.2%) from their portfolio in Q4 2025, for an estimated $29,974,810
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LIQUIDIA TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $LQDA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/13/2026
- BTIG issued a "Buy" rating on 12/26/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/04/2025
- Needham issued a "Buy" rating on 11/04/2025
To track analyst ratings and price targets for LIQUIDIA TECHNOLOGIES, check out Quiver Quantitative's $LQDA forecast page.
LIQUIDIA TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $LQDA recently. We have seen 4 analysts offer price targets for $LQDA in the last 6 months, with a median target of $51.0.
Here are some recent targets:
- Serge Belanger from Needham set a target price of $52.0 on 02/25/2026
- Julian Harrison from BTIG set a target price of $49.0 on 01/13/2026
- Amy Li from Jefferies set a target price of $55.0 on 01/13/2026
- Andrew S. Fein from HC Wainwright & Co. set a target price of $50.0 on 11/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.